ZA954775B - Energy substrates - Google Patents

Energy substrates

Info

Publication number
ZA954775B
ZA954775B ZA954775A ZA954775A ZA954775B ZA 954775 B ZA954775 B ZA 954775B ZA 954775 A ZA954775 A ZA 954775A ZA 954775 A ZA954775 A ZA 954775A ZA 954775 B ZA954775 B ZA 954775B
Authority
ZA
South Africa
Prior art keywords
energy substrates
substrates
energy
Prior art date
Application number
ZA954775A
Other languages
English (en)
Inventor
Rolf Ekroth
Jan Wernerman
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of ZA954775B publication Critical patent/ZA954775B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA954775A 1994-06-10 1995-06-09 Energy substrates ZA954775B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402027A SE9402027D0 (sv) 1994-06-10 1994-06-10 Energy substrates

Publications (1)

Publication Number Publication Date
ZA954775B true ZA954775B (en) 1996-02-08

Family

ID=20394327

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA954775A ZA954775B (en) 1994-06-10 1995-06-09 Energy substrates

Country Status (4)

Country Link
AU (1) AU2758495A (xx)
SE (1) SE9402027D0 (xx)
WO (1) WO1995034301A1 (xx)
ZA (1) ZA954775B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859001A (en) 1996-01-11 1999-01-12 University Of Florida Research Foundation, Inc. Neuroprotective effects of polycyclic phenolic compounds
US5880098A (en) * 1996-04-12 1999-03-09 Pharmacia & Upjohn Aktiebolag Therapeutic treatment
PL369552A1 (pl) * 2004-08-12 2006-02-20 Sgp & Sons Ab Preparat farmaceutyczny lub/i żywieniowy lub/i laboratoryjny wzmagający, wspomagający funkcjonowanie komórek nerwowych i układu nerwowego oraz zastosowanie preparatu farmaceutycznego lub/i żywieniowego w procesie ochrony funkcji układu nerwowego oraz zastosowanie preparatu do ochrony wzrostu stymulacji namnażania i zapobiegania apoptozie komórek nerwowych
EP1887862A4 (en) * 2005-05-26 2012-06-06 Ben O'mar Arrington PRESERVATION SOLUTION FOR ORGANS AND BIOLOGICAL TISSUE
PL379512A1 (pl) * 2006-04-21 2007-10-29 Sgp & Sons Ab Nowe metody i ich zastosowanie
JP5735274B2 (ja) * 2007-07-02 2015-06-17 エントレス・アクチボラゲットＥｎｔｒｅｓｓ Ａｂ 既知の薬理活性化合物の新たな用途
WO2017192413A1 (en) 2016-05-01 2017-11-09 The Regents Of The University Of California Glutarate compounds for treating ischemia-reperfusion injuries
EP3893862B1 (en) 2018-12-14 2023-11-22 National Taiwan University A stable cardioplegic solution for cardiac surgery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0054635B1 (de) * 1980-12-23 1985-02-13 Dr. Franz Köhler Chemie GmbH Protektive Lösung für Herz und Niere und Verfahren zu deren Herstellung
ATE88631T1 (de) * 1986-09-17 1993-05-15 Clintec Nutrition Co Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
SE8704217D0 (sv) * 1987-10-29 1987-10-29 Vinnars Erik Ab Aminosyrakomposition for parenteral neringstillforsel
US4988515A (en) * 1988-01-28 1991-01-29 The Regents Of The Univ. Of Calif. Cardioplegic solution
DE3943424A1 (de) * 1989-12-30 1991-07-04 Nephro Medica Pharma Infusions- und injektionsloesung zur intravenoesen verabreichung
SE9201584D0 (sv) * 1992-05-20 1992-05-20 Vinnars Erik Ab Use of alpha-ketoglutarate

Also Published As

Publication number Publication date
SE9402027D0 (sv) 1994-06-10
AU2758495A (en) 1996-01-05
WO1995034301A1 (en) 1995-12-21

Similar Documents

Publication Publication Date Title
GB9518424D0 (en) Turbines
GB2293628B (en) Turbines
ZA954775B (en) Energy substrates
GB9505442D0 (en) Structural component
GB2294215A9 (en) Power coating
AU3098695A (en) Energy sources
GB2287969B (en) Structural component
AU1463595A (en) Timer arrangements
AU4039795A (en) Solar still
HU9402476D0 (en) (piperidino-alkyl)-aryl-ethers
ZA961629B (en) Photovoltaic arrangement
PL306261A1 (en) Concentrator
CA74714S (en) Can
ZA946119B (en) Panels
GB2294888B (en) Coated substrates
AU784P (en) BLONDIE Chamelaucium megalopetalum x uncinatum
CA73893S (en) Brief
HU600U (en) Angel-shaped figure
ZA958599B (en) Panel-like structure
AUPM999894A0 (en) Solar still
IL111875A0 (en) Sun strackers
AUPN008794A0 (en) Solar oven
AUPN010894A0 (en) Solar heating equipment
GB9420412D0 (en) Turbines
GB9408939D0 (en) Cell modification